Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > History Repeats

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Nov 08, 2023 11:31am

115 Views

Post# 35723743

RE:RE:RE:RE:RE:RE:RE:History Repeats

My absolute favorite is when you dopes accuse people of speculation then, in the same paragraph, of sorts, wildly speculate. Do you not realize that when you're typing, albeit shoddily?

Yeah... I said I was holding. There's no need to tell me to keep holding, I've said it repeatedly, I will be holding until that glorious day. We have as many days together as it takes, exciting.

Ah there we go, now the new stock to pump as an alternative to ours. That clown Deviner does that on Stocktwits. He's pumping SGML, and that's getting beat up as bad as we are.

You guys stink at subterfuge.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing